Neuraxis, INC (New York Stock Exchange Arca:NRXS)
| Market Cap | 85.22M+118.2% |
| Revenue (ttm) | 5.32M+65.2% |
| Net Income | -7.87M-9.7% |
| EPS | -0.77+26.0% |
| Shares Out | 12.48M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 66,036 |
| Open | 6.72 |
| Previous Close | 6.78 |
| Day's Range | 6.60 - 7.04 |
| 52-Week Range | 2.21 - 9.33 |
| Beta | 1.36 |
| Analysts | Buy |
| Price Target | 8.00(+17.13%) |
| Earnings Date | Nov 9, 2026 |
Insiders here have filed 9 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About NRXS
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$NRXS stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NRXS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NRXS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NRXS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
NRXS Revenue by Segment or Geography
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New NRXS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NRXS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NRXS
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.34M |
| VXFVanguard Extended Market ETF | $658.44K |
| IWCiShares Micro-Cap ETF | $207.54K |
| BUSMEA Series Trust - EA Bridgeway Ultra-Small Company Market ETF | $110.00K |
Estimated from each fund’s disclosed top holdings × AUM
NRXS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from NRXS’s recent data — informational, not investment advice